2005 -- H 5107 SUBSTITUTE A | |
======= | |
LC00295/SUB A | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2005 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO HEALTH AND SAFETY | |
|
      |
|
      |
     Introduced By: Representatives Sullivan, Corvese, Moura, McNamara, and Costantino | |
     Date Introduced: January 18, 2005 | |
     Referred To: House Corporations | |
It is enacted by the General Assembly as follows: | |
1-1 |
     SECTION 1. Title 23 of the General Laws entitled "Health and Safety" is hereby |
1-2 |
amended by adding thereto the following chapter: |
1-3 |
     CHAPTER 25.4 |
1-4 |
UTILIZATION OF UNUSED PRESCRIPTION DRUGS ACT |
1-5 |
      |
1-6 |
     23-25.4-1. Title. -- This act may be cited as the "Utilization of Unused Prescription |
1-7 |
Drugs Act." |
1-8 |
     23-25.4-2. Legislative purpose. -- The general assembly has determined that the high |
1-9 |
cost of prescription drugs is a burden on the uninsured who may forego the drugs they need or |
1-10 |
take only partial doses which can ultimately increase health costs. The general assembly has also |
1-11 |
determined that many nursing facilities and assisted living residences destroy quantities of unused |
1-12 |
but viable prescription medications when residents pass away or when medications otherwise are |
1-13 |
no longer needed by the resident. In an effort to improve the quality, efficiency and utilization of |
1-14 |
the state's health care system, the general assembly hereby establishes a voluntary statewide pilot |
1-15 |
program allowing nursing facilities and assisted living residences to transfer from their facilities |
1-16 |
unused prescription drugs to authorized participating pharmacies for distribution to medically |
1-17 |
indigent Rhode Island residents. |
1-18 |
     23-25.4-3. Definitions. – For the purposes of this chapter: |
1-19 |
     (a) "Assisted living residence" has the same meaning as such term is defined in section |
2-1 |
23-17.4-2 and the regulations promulgated thereunder. |
2-2 |
     (b) "Blister packages' means multi-dose containers of a specific medication repackaged |
2-3 |
by the pharmacy in accordance with section 13.7 of the regulations promulgated under chapter |
2-4 |
19.1 of title 5 and intended for a specific patient. |
2-5 |
     (c) "Cancer drugs" means any of several drugs that control or kill neoplastic cells, |
2-6 |
commonly referred to as "cancer-fighting chemotherapy" to destroy cancer cells. |
2-7 |
     (d) "Health care prescriber" means any of the following persons licensed and authorized |
2-8 |
to prescribe drugs or to provide medical, dental, or other health-related diagnoses, care of |
2-9 |
treatment within the scope of their professional license: |
2-10 |
     (i) A physician holding a current license to practice medicine pursuant to chapter 37 of |
2-11 |
title 5; |
2-12 |
     (ii) A certified registered nurse practitioner licensed pursuant to chapter 34 of title 5; |
2-13 |
     (iii) A physician assistant licensed pursuant to chapter 54 of title 5; |
2-14 |
     (iv) A dentist licensed pursuant to chapter 31.1 of title 5; |
2-15 |
     (v) An optometrist licensed pursuant to chapter 35 of title 5; and |
2-16 |
     (vi) A pharmacist licensed pursuant to chapter 19.1 of title 5. |
2-17 |
     (vii) A nurse – midwife licensed pursuant to section 23-13-9 of chapter 13 of title 23; and |
2-18 |
     (viii) A psychiatric and mental health clinical nurse specialist licensed pursuant to chapter |
2-19 |
34 of title 5. |
2-20 |
     (e) "Medically indigent" means a person eligible to receive Medicaid or Medicare or a |
2-21 |
person who has no health insurance and who otherwise lacks reasonable means to purchase |
2-22 |
prescribed drugs. |
2-23 |
     (f) "Charitable clinic" means an organized ambulatory care facility licensed pursuant to |
2-24 |
chapter 17 of title 23 organized as a nonprofit corporation pursuant to section 7-6-2 that: |
2-25 |
     (1) Holds a valid exemption from federal income taxation issued pursuant to Section |
2-26 |
501(a) of the Internal Revenue Code (26 U.S.C., Section 501(1); |
2-27 |
     (2) Is listed as an exempt organization under 501(c) of the Internal Revenue Code (26 |
2-28 |
U.S.C., Section 501(c); |
2-29 |
      (3) Has a licensed outpatient pharmacy located at the organized ambulatory care or a |
2-30 |
contract with a retail pharmacy. |
2-31 |
     (g) "Prescription drug" means a drug which may be dispensed only upon prescription by |
2-32 |
a health care prescriber authorized by his or her licensing authority and which is approved for |
2-33 |
safety and effectiveness as a prescription drug under Section 505 or 507 of the Federal Food, |
2-34 |
Drug and Cosmetic Act (52 Stat. 1040 (1938), 21 U.S.C.A., Section 301). |
3-1 |
     (h) "Unit-dose container" is one that is designed to hold a quantity of a drug intended for |
3-2 |
use as a single dose and used promptly after the container is opened. The immediate container, |
3-3 |
and/or the outer container or protective packaging shall be designed to show evidence of any |
3-4 |
tampering with the contents. Each individual container shall be fully identifiable containing a |
3-5 |
single dose of a single entity and shall protect the integrity of the dosage form. Labeling shall be |
3-6 |
in accordance with USP standards compendia and federal and state law and shall include the |
3-7 |
identity, quantity, and strength of the product, name of the manufacturer, and lot number and |
3-8 |
expiration date of the article. |
3-9 |
     23-25.4-4. Program established. -- (a) The department of health and the board of |
3-10 |
pharmacy shall jointly develop and implement a pilot program consistent with public health and |
3-11 |
safety through which unused prescription drugs, other than prescription drugs defined as |
3-12 |
controlled substances in section 21-28-1.02, may be transferred from nursing facilities or assisted |
3-13 |
living residences that centrally store prescription drugs and are licensed at the M1 licensure level |
3-14 |
by the department of health to pharmacies authorized for the purpose of re-dispensing the |
3-15 |
medication to Rhode Island residents who are medically indigent. |
3-16 |
      (b) The pilot program shall conform to the requirements established in rules promulgated |
3-17 |
by the state department of health and the board of pharmacy. The pilot program shall remain in |
3-18 |
effect until January 1, 2007. |
3-19 |
      (c) The state department of health and the board of pharmacy shall review and evaluate |
3-20 |
the pilot program and shall submit a report and any recommendations to the governor, the speaker |
3-21 |
of the house of representatives, and the president of the senate on or before January 1, 2007. |
3-22 |
      (d) Beginning January 1, 2006, the department of health and the board of pharmacy shall |
3-23 |
implement statewide a program consistent with public health and safety through which unused |
3-24 |
prescription drugs, other than prescription drugs defined as controlled substances in section 21- |
3-25 |
28-1.02, may be transferred from nursing facilities of assisted living residences or to pharmacies |
3-26 |
authorized by the board for the purpose of re-dispensing the unused prescription drugs to Rhode |
3-27 |
Island residents who are medically indigent. |
3-28 |
      (e) The department of health and the board of pharmacy shall promulgate rules and |
3-29 |
establish procedures necessary to implement the program established pursuant to this chapter. |
3-30 |
      (f) The board of pharmacy shall provide technical assistance to entities who may wish to |
3-31 |
participate in the program. |
3-32 |
     23-25.4-5. Criteria. -- The following criteria shall be used in soliciting and accepting |
3-33 |
unused prescription drugs for use pursuant to this chapter: |
3-34 |
     (a) Nursing facilities and assisted living residences that have entered into an agreement to |
4-1 |
participate with an eligible charitable clinic shall solicit residents to participate in the program by |
4-2 |
requiring the residents to sign a statement whereby their excess and otherwise eligible unused |
4-3 |
prescription drugs shall be donated to a specific pharmacy associated with an eligible charitable |
4-4 |
clinic for the purpose of re-dispensing to eligible recipients of such prescription drugs. |
4-5 |
Participation in this program by residents of participating nursing facilities and assisted living |
4-6 |
residences shall be strictly voluntary. |
4-7 |
     (b) Only prescription drugs in their original sealed multi-dose blister packages, unit dose |
4-8 |
containers or perforated blister packages shall be accepted and re-dispensed; |
4-9 |
     (c) Expired prescription drugs shall not be accepted; |
4-10 |
     (d) A prescription drug shall not be accepted or re-dispensed if the pharmacist accepting |
4-11 |
or re-dispensing the drug, in his or her judgment has reason to believe that the drug is adulterated |
4-12 |
mislabeled, or has been improperly stored; |
4-13 |
     (e) No controlled substances shall be accepted; and |
4-14 |
     (f) Subject to the limitation specified in this section, unused prescription drugs dispensed |
4-15 |
for purposes of a medical assistance program may be accepted and re-dispensed pursuant to this |
4-16 |
chapter. |
4-17 |
     23-25.4-6. Participation. -- (a) Participation in the "Utilization of Unused Prescription |
4-18 |
Drugs Act" by individual residents of any assisted living residence or nursing facility, |
4-19 |
pharmacies, nursing facilities, assisted living residences, charitable clinics or prescription drug |
4-20 |
manufacturers shall be voluntary. Nothing in this chapter shall require any resident of any |
4-21 |
assisted living residence or nursing facility, pharmacy, pharmacists, charitable clinic or |
4-22 |
prescription drug manufacturer to participate in the program. |
4-23 |
     (b) A pharmacy operating in conjunction with a charitable clinic that meets the eligibility |
4-24 |
requirements established in this chapter may: |
4-25 |
     (1) Re-dispense prescription drugs donated pursuant to this chapter to persons who are |
4-26 |
medically indigent residents of Rhode Island. |
4-27 |
     (c) A pharmacy operating in conjunction with a charitable clinic wherein both meet the |
4-28 |
eligibility requirements established and authorized by this chapter and that accepts donated |
4-29 |
prescription drugs shall: |
4-30 |
     (1) Comply with all applicable federal and state laws relating to the storage, distribution, |
4-31 |
and dispensing of prescription drugs; |
4-32 |
     (2) Inspect all prescription drugs prior to re-dispensing the prescription drugs to |
4-33 |
determine that such drugs are not adulterated; and |
4-34 |
     (3) Re-dispense prescription drugs only pursuant to a valid prescription issued by a |
5-1 |
health care prescriber. |
5-2 |
     (d) Prescription drugs donated pursuant to this chapter shall not be resold. |
5-3 |
     23-25.4-7. Liability. -- (a) For matters related only to the lawful donation, acceptance, or |
5-4 |
re-dispensing of prescription drugs under this chapter, the following persons and entities, in |
5-5 |
compliance with the criteria set forth in this chapter, in the absence of bad faith or gross |
5-6 |
negligence, shall not be subject to criminal or civil liability for injury other than death, or loss to |
5-7 |
person or property, or professional disciplinary action: |
5-8 |
     (1) The board of pharmacy; |
5-9 |
     (2) Any resident of a nursing facility or assisted living residence who agrees to donate |
5-10 |
unused prescription drugs, or his/her next of kin or legal guardian; |
5-11 |
     (3) The department of mental health, retardation and hospitals; |
5-12 |
     (4) Any prescription drug manufacturer, governmental entity, nursing facility, or assisted |
5-13 |
living residence who participates in the program for the reuse of prescription drugs pursuant to |
5-14 |
this chapter; |
5-15 |
     (5) Any prescription drug manufacturer or its representative that directly donates |
5-16 |
prescription drugs in professional samples to a charitable clinic or a pharmacy pursuant to this |
5-17 |
chapter; |
5-18 |
     (6) Any health care prescriber or pharmacy that accepts or dispenses operating in |
5-19 |
conjunction with a charitable clinic that accepts or re-dispenses prescription drugs pursuant to this |
5-20 |
chapter; and |
5-21 |
     (7) Any pharmacy or pharmacist operating in conjunction with a charitable clinic, or |
5-22 |
other state-contracted pharmacy that employs a health care professional who accepts or can |
5-23 |
legally dispense prescription drugs pursuant to this chapter. |
5-24 |
     (b) For matters related to the donation, acceptance, or dispensing of a prescription drug |
5-25 |
manufactured by the prescription drug manufacturer that is donated by any entity pursuant to this |
5-26 |
chapter, a prescription drug manufacturer shall not, in the absence of bad faith be subject to |
5-27 |
criminal or civil liability for injury death, or loss to person or property including, but not limited |
5-28 |
to, liability for failure to transfer or communicate product or consumer information or the |
5-29 |
expiration date of the donated prescription drug. |
5-30 |
     23-25.4-8. Rules. -- (a) The board of pharmacy shall promulgate emergency rules by |
5-31 |
December 1, 2005, to implement the provisions of this chapter. Permanent rules shall be |
5-32 |
promulgated pursuant to the administrative procedures act. Such rules shall include: |
5-33 |
     (1) Eligibility criteria for pharmacies and charitable clinics authorized to receive and |
5-34 |
dispense donated prescription drugs pursuant to this chapter; |
6-1 |
     (2) Establishment of a formulary which shall include all prescription drugs approved by |
6-2 |
the federal Food and Drug Administration; |
6-3 |
     (3) Standards and procedures for transfer, acceptance, safe storage, security, and |
6-4 |
dispensing of donated prescription drugs; |
6-5 |
     (4) A process for seeking input from the state department of health in establishing |
6-6 |
provisions which affect nursing homes and assisted living residences; |
6-7 |
     (5) A process for seeking input form the department of mental health, retardation and |
6-8 |
hospitals in establishing provisions which affect mental heath and substance abuse clients; |
6-9 |
     (6) Standards and procedures for inspecting donated prescription drugs to ensure that the |
6-10 |
drugs are in compliance with the provisions of this chapter and to ensure that, in the professional |
6-11 |
judgment of the pharmacist, the medications meet all federal and state standards for product |
6-12 |
integrity; |
6-13 |
     (7) Procedures for destruction of medications that are donated which are controlled |
6-14 |
substances; |
6-15 |
     (8) Procedures for verifying whether the pharmacy and responsible pharmacist |
6-16 |
participating in the program are licensed and in good standing with the board of pharmacy; |
6-17 |
     (9) Establishment of standards for acceptance of unused prescription medications from |
6-18 |
assisted living residences; and |
6-19 |
     (10) Any other standards and procedures the board of pharmacy deems appropriate or |
6-20 |
necessary to implement the provisions of this chapter. |
6-21 |
     (b) In accordance with the rules and procedures of the program established pursuant to |
6-22 |
this section, a resident of a nursing facility or assisted living residence, or the representative or |
6-23 |
guardian of a resident may donate unused prescription medications, other than prescription drugs |
6-24 |
defined as controlled dangerous substances, for dispensation to medically indigent persons. |
6-25 |
     23-25.4-9. Prohibitions. -- It shall be unlawful for any person, firm or corporation to: |
6-26 |
     (a) Forge or increase the quantity of drug in any prescription, or to present a prescription |
6-27 |
bearing forged, fictitious or altered information or to possess any drug secured by such forged, |
6-28 |
fictitious or altered prescription; |
6-29 |
     (b) Sell, offer for sale, barter or give away any unused quantity of drugs obtained by |
6-30 |
prescription, except through a program pursuant to this chapter or as otherwise provided by the |
6-31 |
board of pharmacy; |
6-32 |
     (c) Sell, offer for sale, barter or give away any drugs damaged by fire, water, or other |
6-33 |
causes without first obtaining the written approval of the board of pharmacy or the state |
6-34 |
department of health; |
7-1 |
     (d) Enter into any arrangement whereby prescription orders are received, or prescriptions |
7-2 |
delivered at a place other than the pharmacy in which they are compounded and dispensed. |
7-3 |
However, nothing in this paragraph shall prevent a pharmacist or an employee of the pharmacy |
7-4 |
from personally receiving a prescription or delivering a legally filled prescription at a residence, |
7-5 |
office or place of employment of the patient for whom the prescription was written. Nothing in |
7-6 |
this paragraph shall prevent veterinary prescription drugs from being shipped directly from a |
7-7 |
wholesaler or distributor to a client; provided, such drugs may be dispensed only on prescription |
7-8 |
of a licensed veterinarian and only when an existing veterinary-client-patient relationship exists; |
7-9 |
     (e) Sell, offer for sale or barter or buy any professional samples except through a program |
7-10 |
established pursuant to this chapter. For purpose of this subsection, "professional samples" |
7-11 |
means complimentary drugs packaged in accordance with federal and state statutes and |
7-12 |
regulations and provided to a licensed practitioner free of charge by manufacturers or distributor |
7-13 |
for the purpose of being distributed free of charge in such package by the licensed practitioner to |
7-14 |
a patient; |
7-15 |
     (f) Refuse to permit or otherwise prevent members of the board of pharmacy or such |
7-16 |
representative thereof from entering and inspecting any and all places, including premises, |
7-17 |
equipment, contents, and records, where drugs, medicine, chemicals or poisons are stored, sold, |
7-18 |
vended, given away, compounded, dispensed or manufactured; or |
7-19 |
     (g) Possess dangerous drugs without a valid prescription or a valid license to possess |
7-20 |
such drugs. |
7-21 |
     SECTION 2. This act shall take effect upon passage. |
      | |
======= | |
LC00295/SUB A | |
======== | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY | |
*** | |
8-1 |
     This act would create the Utilization of Unused Prescriptions Medications Act which |
8-2 |
would authorize the department of health and the board of pharmacy to create and implement a |
8-3 |
voluntary statewide pilot program allowing nursing homes, assisted living centers and |
8-4 |
prescription drug manufacturers to transfer from their facilities unused prescription medications |
8-5 |
to authorized participating pharmacies for distribution to medically indigent Rhode Island |
8-6 |
residents. This act would establish standards for authorizing participants under this chapter, |
8-7 |
would authorize the board of pharmacy to promulgate program rules and establish criteria for |
8-8 |
accepting unused prescription drugs for use under the chapter. This act would also establish the |
8-9 |
exclusion of liabilities for participants in the program and determine prohibited criminal acts |
8-10 |
under the chapter. |
8-11 |
     This act would take effect upon passage. |
      | |
======= | |
LC00295/SUB | |
======= |